DUBLIN--(BUSINESS WIRE)--The "Radiotherapy Market by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global radiotherapy market is expected to grow at a CAGR of 5.6% from 2019 to reach $10.15 billion by 2025
The factors such as growing awareness about the benefits of radiotherapy for cancer treatment, increasing incidence & prevalence of cancer, and technological advancements in the field of radiotherapy are driving the growth of global radiotherapy market.
Moreover, opportunities from developing economies and growing government investments for the treatment of cancer further support the growth of this market. However, high cost and complexities associated with the radiotherapy procedures, a paucity of skilled healthcare professionals, and lack of advanced infrastructure facilities hinder the growth of this market.
Based on product type, radiotherapy devices segment is estimated to command the largest share of the overall radiotherapy market in 2019 and is expected to continue its dominance during the forecast period, mainly due to higher demand for linear accelerators and particle therapy systems with increasing adoption of radiation therapy procedures for the treatment of various types of cancers.
Key players operating in the global radiotherapy market are
- Accuray Incorporated
- C. R. Bard Inc.
- Elekta AB
- Hitachi Ltd.
- Ion Beam Applications S.A.
- Isoray Inc.
- Mevion Medical Systems Inc.
- Optivus Proton Therapy Inc.
- P-Cure Ltd.
- Panacea Medical Technologies Pvt. Ltd.
- Provison Healthcare LLC
- Theragenics Corporation.
- Varian Medical Systems Inc.
- ViewRay Inc.
Key Topics Covered:
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1.1. Secondary Research
2.1.2. Primary Research
3. Executive Summary
4. Market Insights
4.2. Market Dynamics
220.127.116.11. Growing Awareness About the Benefits of Radiotherapy for Cancer Treatment
18.104.22.168. Increasing Incidence & Prevalence of Cancer
22.214.171.124. Technological Advancements in the Field of Radiotherapy
126.96.36.199. High Cost and Complexities Associated with Radiotherapy Procedures
188.8.131.52. Paucity of Skilled Healthcare Professionals
184.108.40.206. Lack of Advanced Infrastructure Facilities
220.127.116.11. Difficulties in Visualizing Tumours during Radiotherapy Procedures
18.104.22.168. Risks due to Radiation Exposures
22.214.171.124. Significant Opportunities from Developing Economies
126.96.36.199. Growing Government Investment for Treatment of Cancer
5. Radiotherapy Market, by Procedure
5.2. External Beam Radiotherapy
5.2.1. Linac Based Teletherapy
5.2.2. Proton Therapy
5.2.3. Cobalt-60 Based Teletherapy
5.3. Internal Beam Radiotherapy
5.3.2. Systemic Radiotherapy
6. Radiotherapy Market, by Product
6.2. Radiotherapy Devices
6.2.1. External Beam Radiotherapy Systems
188.8.131.52. Conventional Linear Accelerators
184.108.40.206. Conventional Co-60 Teletherapy Units
220.127.116.11. Advanced Stereotactic Radiotherapy Systems
18.104.22.168.1. Gamma Knife
22.214.171.124. Proton Therapy Systems
6.2.2. Internal Beam Radiotherapy Systems
126.96.36.199. Brachytherapy Systems
188.8.131.52.1. Electronic Brachytherapy Products
6.3. Radiotherapy Consumables and Accessories
6.3.1. Internal Beam Radiotherapy Consumables and Accessories
184.108.40.206. Brachytherapy Consumables & Accessories
220.127.116.11.1. Brachytherapy Applicators
18.104.22.168.2. Brachytherapy Seeds
22.214.171.124. Systemic Radiation Therapy
126.96.36.199.1. Iobenguane (I-131)
7. Radiotherapy Market, by Technology
7.2. External Beam Radiotherapy
7.2.1. Intensity-Modulated Radiation Therapy (IMRT)
7.2.2. Image-Guided Radiation Therapy (IGRT)
7.2.3. Stereotactic Radiation Therapy (SRT)
7.2.4. 3D Conformal Radiation Therapy (3D-CRT)
7.2.5. Particle Therapy
7.3. Internal Beam Radiotherapy
188.8.131.52. High-Dose Rate Brachytherapy
184.108.40.206. Low-Dose Rate Brachytherapy
220.127.116.11. Image-Guided Brachytherapy
18.104.22.168. Pulse-Dose Rate Brachytherapy
7.3.2. Systemic Radiation Therapy
22.214.171.124. Intravenous Radiotherapy
126.96.36.199. Oral Radiotherapy
8. Radiotherapy Market, by Application
8.2. Breast Cancer
8.3. Prostate Cancer
8.4. Lung Cancer
8.5. Brain Tumour
8.6. Head and Neck Cancer
8.7. Colorectal Cancer
8.8. Cervical Cancer
9. Radiotherapy Market, by End User
9.3. Independent Radiotherapy Centres
9.4. Cancer Research Institutes
10. Radiotherapy Market, by Geography
10.2. North America
10.3.6. Rest of Europe
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.6. Middle East & Africa
11. Competitive Landscape
11.1. Competitive Growth Strategies
11.2. Competitive Benchmarking
11.3. Market Share Analysis
12. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/b61xm4